Literature DB >> 25480297

Environment drives selection and function of enhancers controlling tissue-specific macrophage identities.

David Gosselin1, Verena M Link2, Casey E Romanoski1, Gregory J Fonseca1, Dawn Z Eichenfield1, Nathanael J Spann1, Joshua D Stender1, Hyun B Chun1, Hannah Garner3, Frederic Geissmann3, Christopher K Glass4.   

Abstract

Macrophages reside in essentially all tissues of the body and play key roles in innate and adaptive immune responses. Distinct populations of tissue macrophages also acquire context-specific functions that are important for normal tissue homeostasis. To investigate mechanisms responsible for tissue-specific functions, we analyzed the transcriptomes and enhancer landscapes of brain microglia and resident macrophages of the peritoneal cavity. In addition, we exploited natural genetic variation as a genome-wide "mutagenesis" strategy to identify DNA recognition motifs for transcription factors that promote common or subset-specific binding of the macrophage lineage-determining factor PU.1. We find that distinct tissue environments drive divergent programs of gene expression by differentially activating a common enhancer repertoire and by inducing the expression of divergent secondary transcription factors that collaborate with PU.1 to establish tissue-specific enhancers. These findings provide insights into molecular mechanisms by which tissue environment influences macrophage phenotypes that are likely to be broadly applicable to other cell types.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25480297      PMCID: PMC4364385          DOI: 10.1016/j.cell.2014.11.023

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  50 in total

1.  IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia.

Authors:  Yaming Wang; Kristy J Szretter; William Vermi; Susan Gilfillan; Cristina Rossini; Marina Cella; Alexander D Barrow; Michael S Diamond; Marco Colonna
Journal:  Nat Immunol       Date:  2012-06-24       Impact factor: 25.606

2.  Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages.

Authors:  Serena Ghisletti; Iros Barozzi; Flore Mietton; Sara Polletti; Francesca De Santa; Elisa Venturini; Lorna Gregory; Lorne Lonie; Adeline Chew; Chia-Lin Wei; Jiannis Ragoussis; Gioacchino Natoli
Journal:  Immunity       Date:  2010-03-04       Impact factor: 31.745

3.  Synaptic pruning by microglia is necessary for normal brain development.

Authors:  Rosa C Paolicelli; Giulia Bolasco; Francesca Pagani; Laura Maggi; Maria Scianni; Patrizia Panzanelli; Maurizio Giustetto; Tiago Alves Ferreira; Eva Guiducci; Laura Dumas; Davide Ragozzino; Cornelius T Gross
Journal:  Science       Date:  2011-07-21       Impact factor: 47.728

4.  Latent enhancers activated by stimulation in differentiated cells.

Authors:  Renato Ostuni; Viviana Piccolo; Iros Barozzi; Sara Polletti; Alberto Termanini; Silvia Bonifacio; Alessia Curina; Elena Prosperini; Serena Ghisletti; Gioacchino Natoli
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

5.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

Review 6.  Development of monocytes, macrophages, and dendritic cells.

Authors:  Frederic Geissmann; Markus G Manz; Steffen Jung; Michael H Sieweke; Miriam Merad; Klaus Ley
Journal:  Science       Date:  2010-02-05       Impact factor: 47.728

7.  Coregulation of transcription factor binding and nucleosome occupancy through DNA features of mammalian enhancers.

Authors:  Iros Barozzi; Marta Simonatto; Silvia Bonifacio; Lin Yang; Remo Rohs; Serena Ghisletti; Gioacchino Natoli
Journal:  Mol Cell       Date:  2014-05-08       Impact factor: 17.970

8.  Selective inhibition of tumor oncogenes by disruption of super-enhancers.

Authors:  Jakob Lovén; Heather A Hoke; Charles Y Lin; Ashley Lau; David A Orlando; Christopher R Vakoc; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

9.  Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.

Authors:  Minna U Kaikkonen; Nathanael J Spann; Sven Heinz; Casey E Romanoski; Karmel A Allison; Joshua D Stender; Hyun B Chun; David F Tough; Rab K Prinjha; Christopher Benner; Christopher K Glass
Journal:  Mol Cell       Date:  2013-08-08       Impact factor: 17.970

10.  Predicting enhancer transcription and activity from chromatin modifications.

Authors:  Yun Zhu; Lin Sun; Zhao Chen; John W Whitaker; Tao Wang; Wei Wang
Journal:  Nucleic Acids Res       Date:  2013-09-12       Impact factor: 16.971

View more
  517 in total

1.  Transcriptome analysis highlights the conserved difference between embryonic and postnatal-derived alveolar macrophages.

Authors:  Sophie L Gibbings; Rajni Goyal; A Nicole Desch; Sonia M Leach; Miglena Prabagar; Shaikh M Atif; Donna L Bratton; William Janssen; Claudia V Jakubzick
Journal:  Blood       Date:  2015-07-31       Impact factor: 22.113

Review 2.  Making the case for chromatin profiling: a new tool to investigate the immune-regulatory landscape.

Authors:  Deborah R Winter; Steffen Jung; Ido Amit
Journal:  Nat Rev Immunol       Date:  2015-08-14       Impact factor: 53.106

Review 3.  Exploiting genomics and natural genetic variation to decode macrophage enhancers.

Authors:  Casey E Romanoski; Verena M Link; Sven Heinz; Christopher K Glass
Journal:  Trends Immunol       Date:  2015-08-19       Impact factor: 16.687

Review 4.  The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis.

Authors:  Ido Amit; Deborah R Winter; Steffen Jung
Journal:  Nat Immunol       Date:  2016-01       Impact factor: 25.606

5.  Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist.

Authors:  Michael R McKeown; M Ryan Corces; Matthew L Eaton; Chris Fiore; Emily Lee; Jeremy T Lopez; Mei Wei Chen; Darren Smith; Steven M Chan; Julie L Koenig; Kathryn Austgen; Matthew G Guenther; David A Orlando; Jakob Lovén; Christian C Fritz; Ravindra Majeti
Journal:  Cancer Discov       Date:  2017-07-20       Impact factor: 39.397

Review 6.  Metabolic and Epigenetic Coordination of T Cell and Macrophage Immunity.

Authors:  Anthony T Phan; Ananda W Goldrath; Christopher K Glass
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

7.  Lymphatic Endothelial Cells Are Essential Components of the Subcapsular Sinus Macrophage Niche.

Authors:  Isabelle Mondor; Myriam Baratin; Marine Lagueyrie; Lisa Saro; Sandrine Henri; Rebecca Gentek; Delphine Suerinck; Wolfgang Kastenmuller; Jean X Jiang; Marc Bajénoff
Journal:  Immunity       Date:  2019-04-30       Impact factor: 31.745

Review 8.  Multitasking Microglia and Alzheimer's Disease: Diversity, Tools and Therapeutic Targets.

Authors:  Alexandra Grubman; Katja M Kanninen; Tarja Malm
Journal:  J Mol Neurosci       Date:  2016-09-22       Impact factor: 3.444

9.  Reuse of public, genome-wide, murine eosinophil expression data for hypotheses development.

Authors:  Jillian O Grace; Astha Malik; Hadar Reichman; Ariel Munitz; Artem Barski; Patricia C Fulkerson
Journal:  J Leukoc Biol       Date:  2018-05-14       Impact factor: 4.962

Review 10.  Tissue Immunometabolism: Development, Physiology, and Pathobiology.

Authors:  Kevin Man; Vassily I Kutyavin; Ajay Chawla
Journal:  Cell Metab       Date:  2016-09-29       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.